Search

Your search keyword '"death receptors"' showing total 2,968 results

Search Constraints

Start Over You searched for: Descriptor "death receptors" Remove constraint Descriptor: "death receptors"
2,968 results on '"death receptors"'

Search Results

Catalog

Books, media, physical & digital resources

3. Lidocaine could promote the cuproptosis through up-regulating the long noncoding RNA DNMBP-AS1 in Hep-2 cells.

4. The anti-melanoma roles and mechanisms of tricholoma isoflavone derivative CA028.

5. An antibiotic that mediates immune destruction of senescent cancer cells.

6. Unveiling the Mechanisms of Apoptosis Induction by Deep‐Sea‐Derived Polyketide‐Terpenoid Hybrids from Penicillium allii‐sativi: A Focus on Mitochondrial and mTOR Pathways.

7. V‐domain immunoglobulin suppressor of T‐cell activation and programmed death receptor 1 dual checkpoint blockade enhances antitumour immunity and survival in glioblastoma.

8. PD-1 / PD-L1 抑制剂治疗非小细胞肺癌并发免疫 相关不良反应预测模型的构建与验证.

9. A randomized controlled study of neoadjuvant metformin with chemotherapy in nondiabetic breast cancer women: The METNEO study.

10. Immune checkpoints are suppressed during pregnancy following influenza A virus infection.

11. Fisetin reduces the resistance of MOLT-4 and K562 cells to TRAIL-induced apoptosis through upregulation of TRAIL receptors.

12. Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway.

13. Insights into the historical trajectory and research trends of immune checkpoint blockade in colorectal cancer: visualization and bibliometric analysis.

14. Bladder Cancer Treatments in the Age of Personalized Medicine: A Comprehensive Review of Potential Radiosensitivity Biomarkers.

15. Clinical characteristics and prognosis of liver injury induced by immune checkpoint inhibitors in patients with malignancies: A real‐world retrospective study.

16. Amelanotic Melanoma—Biochemical and Molecular Induction Pathways.

17. The autophagy protein RUBCNL/PACER represses RIPK1 kinase-dependent apoptosis and necroptosis.

18. Apoptotic Receptors and CD107a Expression by NK Cells in an Interaction Model with Trophoblast Cells

19. Targeting caspase-8/c-FLIPL heterodimer in complex II promotes DL-mediated cell death.

20. Targeting caspase-8/c-FLIP L heterodimer in complex II promotes DL-mediated cell death.

21. The Effect of Semaglutide on Mortality and COVID-19–Related Deaths: An Analysis From the SELECT Trial.

22. Dichloroacetate reduces cisplatin-induced apoptosis by inhibiting the JNK/14-3-3/Bax/caspase-9 pathway and suppressing caspase-8 activation via cFLIP in murine tubular cells.

23. Reverse hierarchical DED assembly in the cFLIP-procaspase-8 and cFLIP-procaspase-8-FADD complexes.

24. Enhancement of anti-PD-L1 antibody plus anlotinib efficacy due to downregulation of PD-L1 in the micro-conduit endothelium within the tumor: a randomized double-blind trial.

25. The role of programmed death receptor (PD‐)1/PD‐ligand (L)1 in periodontitis and cancer.

26. STAMBP is Required for Long-Term Maintenance of Neural Progenitor Cells Derived from hESCs.

27. Association between programmed cell death ligand-1 expression in patients with cervical cancer and apparent diffusion coefficient values: a promising tool for patient´s immunotherapy selection.

28. Induced Necroptosis and Its Role in Cancer Immunotherapy.

29. Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer.

30. Unlocking Apoptotic Pathways: Overcoming Tumor Resistance in CAR‐T‐Cell Therapy.

31. Potential Role of Tarantula Venom Peptides in Targeting Human Death Receptors: A Computational Study.

32. Strong activation of p53 by actinomycin D and nutlin-3a overcomes the resistance of cancer cells to the pro-apoptotic activity of the FAS ligand.

33. Microglia either promote or restrain TRAIL-mediated excitotoxicity caused by Aβ1−42 oligomers.

34. Expression of Apoptosis, Autophagy and Necroptosis Effectors in Rat Hippocampal Cells after Excessive Fluoride Intake.

35. Acquired Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Resistance of Human Colorectal Cancer Cells Is Linked to Histone Acetylation and Is Synergistically Ameliorated by Combination with HDAC Inhibitors.

36. Inhibitors identify an auxiliary role for mTOR signalling in necroptosis execution downstream of MLKL activation.

37. Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the "all-around warrior" in immunotherapy.

38. Modulation of extrinsic apoptotic pathway by intracellular glycosylation.

39. Construction and validation of a synthetic phage-displayed nanobody library.

40. Picornavirus VP3 protein induces autophagy through the TP53-BAD-BAX axis to promote viral replication.

41. Multiple mechanisms contribute to acquired TRAIL resistance in multiple myeloma.

42. Analysis of efficacy and safety for the combination of tislelizumab and regorafenib in advanced hepatocellular carcinoma: A prospective clinical study.

43. PD-1/PD-L1 信号通路在脓毒症不同器官免疫调控中的研究进展.

44. Research Progress of Necroptosis in Digestive Diseases.

45. SH003 Induces DR5-Mediated Caspase-Dependent Apoptosis of NSCLC Through Inhibition of AKT Survival Pathway.

46. Predictive Value of Lymphocyte‐to‐Neutrophil Ratio and Platelet‐to‐Neutrophil Ratio on PD‐L1 Expression in Lung Cancer.

47. Prospects of compounds of herbal plants as anticancer agents: a comprehensive review from molecular pathways.

48. TLR4 signalling in ischemia/reperfusion injury: a promising target for linking inflammation, oxidative stress and programmed cell death to improve organ transplantation outcomes.

49. Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes.

50. Potential of Polar Lipids Isolated from the Marine Sponge Haliclona (Halichoclona) vansoesti against Melanoma.